Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement

New England Journal of Medicine

Volumn 335, Issue 10, 1996, Pages 696-700

  Bergqvist, David ^a   Benoni, Göran ^b   Björgell, Ola ^b   Fredin, Hans ^b   Hedlundh, Urban ^b   Nicolas, Sylvain ^c   Nilsson, Paul ^b   Nylander, Göran ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Rhône Poulenc Rorer ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; FEMALE; HEMATOMA; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FEMALE; HEMATOMA; HIP PROSTHESIS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; THROMBOEMBOLISM; THROMBOPHLEBITIS; TREATMENT OUTCOME;

EID: 0029818298     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199609053351002     Document Type: Article

References (34)

1. Turpie AGG, Levine MN, Hirsh J, et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315:925-9.
2. Jørgensen LN, Wille-Jørgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993;80:689-704.
3. Paiement GD, Schutzer SF, Wessinger SJ, Harris WH. Influence of prophylaxis on proximal venous thrombus formation after total hip arthroplasty. J Arthroplasty 1992;7:471-5.
4. Mohr DN, Silverstein MD, Murtaugh PA, Harrison JM. Prophylactic agents for venous thrombosis in elective hip surgery: meta-analysis of studies using venographic assessment. Arch Intern Med 1993;153:2221-8.
5. Leizorovicz A, Haugh MC, Chapuis F-R, Samama MM, Boissel J-P. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992;305:913-20.
6. Nurmohamed MT, Rosendaal FR, Büller HR, et al. Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992;340:152-6.
7. Anderson DR, O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J. Efficacy and cost of low-molccular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty. Ann Intern Med 1993;119:1105-12.
8. Borris LC, Lassen MR, Jensen HP, Andersen BS, Poulsen KS. Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery: clinical and economic considerations. Int J Clin Pharmacol Ther 1994;32:262-8.
9. Bergqvist D, Lindgren B, Mätzsch T. Cost-effectiveness of preventing postoperative deep vein thrombosis. In:Hull R, Pineo G, eds. Disorders of thrombosis. Philadelphia: W.B. Saunders, 1996:228-33.
10. Hampson WGJ, Harris FC, Lucas HK, et al. Failure of low-dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty. Lancet 1974;2:795-7.
11. Mannucci PM, Citterio LE, Panajotopoulos N. Low-dose heparin and deep-vein thrombosis after total hip replacement. Thromb Haemost 1976; 36:157-64.
12. Stamatakis JD, Kakkar W, Sagar S, Lawrence D, Nairn D, Bentley PG. Femoral vein thrombosis and total hip replacement. BMJ 1977;2:223-5.
13. Planes A, Vochelle N, Fagola M. Total hip replacement and deep vein thrombosis: a venographic and necropsy study. J Bone Joint Surg Br 1990; 72:9-13.
14. McNally MA, Mollan RAB. Total hip replacement, lower limb blood flow and venous thrombogenesis. J Bone Joint Surg Br 1993;75:640-4.
15. Scurr JH, Coleridge-Smith PD, Hasty JH. Deep venous thrombosis: a continuing problem. BMJ 1988;297:28.
16. Trowbridge A, Boese CK, Woodruff B, Brindley HH Sr, Lowry WE, Spiro TE. Incidence of postnospitaiization proximal deep venous thrombosis after total hip arthroplasty: a pilot study. Clin Orthop 1994;299:203-8.
17. Bergqvist D, Lindblad B. A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 1985; 72:105-8.
18. Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge: an underestimated risk. Arch Surg 1992;127:310-3.
19. Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism: a clinico-pathological study in injured and burned patients. Br J Surg 1961; 48:475-89.
20. Bergqvist D, Fredin H. Pulmonary embolism and mortality in patients with fractured hips - a prospective consecutive series. Eur J Surg 1991; 157:571-4.
21. Schrøder HM, Andreassen M. Autopsy-verified major pulmonary embolism after hip fracture. Clin Orthop 1993;293:196-203.
22. Nicolaides A, Arceius J, Belcaro G, et al. Prevention of venous thromboembolism. Int Angiol 1992;11:151-9.
23. Planes A, Vochelle N, Mazas F, et al. Prevention of postoperative venous thrombosis: a randomized triai comparing untractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988;60:407-10.
24. Eriksson BI, Zachrísson BE, Teger-Nilsson AC, Risberg B. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement. Br J Surg 1988;75:1053-7.
25. Leyvraz PF, Bachmann F, Hoek J, et al. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ 1991;303:543-8. [Erratum, BMJ 1991;303:1243.]
26. Bergqvist D, Lindblad B, Mätzsch T. Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia - is there a risk? Acta Anaesthesiol Scand 1992;36:605-9.
27. Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994;79:1165-77.
28. Ginsberg JS, Caco CC, Brill-Edwards PA, et al. Venous thrombosis in patients who have undergone major hip or knee surgery: detection with compression US and impedance plethysmography. Radiology 1991;181:651-4.
29. Agnelli G, Volpato R, Radicchia S, et al. Detection of asymptomatic deep vein thrombosis by real-time B-mode ultrasonography in hip surgery patients. Thromb Haemost 1992;68:257-60.
30. Wells PS, Lensing AW, Davidson BL, Prins MH, Hirsh J. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery: a meta-analysis. Ann Intern Med 1995; 122:47-53.
31. 125I-fibrinogen test. Acta Radiol Diagn 1981;22:577-80.
32. Dahl OE, Andreassen G, Müller C, et al. The effect of prolonged thromboprophyiaxis with dalteparin on the frequency of deep vein thrombosis (DVT) and pulmonary embolism (PE) 35 days after hip replacement surgery (HRS). Thromb Haemost 1995;73:1094. abstract.
33. Planes A, Vochelle N, Fagola M, et al. Persistence of the risk of deep venous thrombosis after hospital discharge in patients undergoing total hip replacement. Lancet (in press).
34. Warwick D, Williams MH, Bannister GC. Death and thromboembolic disease after total hip replacement: a series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg Br 1995;77:6-10.